IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastomaValentina Folgiero, Angela Mastronuzzi|Oncotarget|2016Cited by 41
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumorsGiada Del Baldo, Angela Mastronuzzi|Frontiers in Immunology|2023Cited by 22
Upfront treatment with <scp>mTOR</scp> inhibitor everolimus in pediatric low‐grade gliomas: A single‐center experienceAntonella Cacchione, Angela Mastronuzzi|International Journal of Cancer|2020Cited by 19